Intravenous Immunoglobulin in Kawasaki Disease-Evolution and Pathogenic Mechanisms

Pallavi L Nadig1, Vibhu Joshi1, Rakesh Kumar Pilania1

  • 1Pediatric Allergy Immunology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India.

Insights

Intravenous immunoglobulin (IVIg) effectively prevents coronary artery aneurysms in Kawasaki disease (KD). This review explores IVIg

Area of Science:

  • Pediatric rheumatology
  • Immunology
  • Vascular biology

Background:

  • Kawasaki disease (KD) is a childhood vasculitis impacting medium vessels, particularly coronary arteries.
  • Coronary artery aneurysms (CAAs) are a major complication, occurring in 25-30% of untreated cases.
  • Intravenous immunoglobulin (IVIg) reduces CAA risk to under 5%, but its immunomodulatory mechanisms are unclear.

Purpose of the Study:

  • To review the potential mechanisms of IVIg's immunomodulatory actions in Kawasaki disease.
  • To summarize evidence on IVIg infusion protocols and dosages for KD treatment.

Main Methods:

  • Review of existing literature on IVIg's effects in Kawasaki disease.
  • Analysis of studies investigating innate and adaptive immune system modulation by IVIg.
  • Examination of data on treatment protocols and dosages.

Main Results:

  • IVIg appears to modulate innate immunity via toll-like receptor pathways, autophagy, apoptosis, neutrophil extracellular traps, and dendritic cells.
  • IVIg also influences adaptive immunity by affecting T-cell differentiation, cytokine release, and regulatory T-cell function.
  • Evidence regarding various IVIg infusion protocols and dosages in KD treatment is summarized.

Conclusions:

  • IVIg exerts immunomodulatory effects on both innate and adaptive immune systems in Kawasaki disease.
  • Understanding these mechanisms can optimize KD treatment strategies and improve patient outcomes.
  • Further research is needed to fully elucidate IVIg's complex actions in KD.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
31
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
32
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9